EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mesenchymal Stromal Cells from Perinatal Tissues as an Alternative for Ex Vivo Expansion of Hematopoietic Progenitor and Stem Cells from Umbilical Cord Blood

Ximena Bonilla, Ana Milena Lara iD, Manuela Llano-León, David A López-González, David G Hernández-Mejía iD, Rosa Helena Bustos iD, Bernardo Camacho-Rodríguez, Ana-María Perdomo-Arciniegas iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms242115544 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Ximena Bonilla und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Biotechnology Unit, Instituto Distrital de Ciencia, Biotecnología e Innovación en Salud, Bogotá 111611, Colombia. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Hematopoietic Stem Cell Transplantation, Hematologic Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science, Technology and Innovation (Colombia) and IDCBIS Resources., Ministerio de Ciencia, Tecnología e Innovación.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Umbilical cord blood (UCB) serves as a source of hematopoietic stem and progenitor cells (HSPCs) utilized in the regeneration of hematopoietic and immune systems, forming a crucial part of the treatment for various benign and malignant hematological diseases. UCB has been utilized as an alternative HSPC source to bone marrow (BM). Although the use of UCB has extended transplantation access to many individuals, it still encounters significant challenges in selecting a histocompatible UCB unit with an adequate cell dose for a substantial proportion of adults with malignant hematological diseases. Consequently, recent research has focused on developing ex vivo expansion strategies for UCB HSPCs. Our results demonstrate that co-cultures with the investigated mesenchymal stromal cells (MSCs) enable a 10- to 15-fold increase in the cellular dose of UCB HSPCs while partially regulating the proliferation capacity when compared to HSPCs expanded with early acting cytokines. Furthermore, the secretory profile of UCB-derived MSCs closely resembles that of BM-derived MSCs. Moreover, both co-cultures exhibit alterations in cytokine secretion, which could potentially impact HSPC proliferation during the expansion process. This study underscores the fact that UCB-derived MSCs possess a remarkably similar supportive capacity to BM-derived MSCs, implying their potential use as feeder layers in the ex vivo expansion process of HSPCs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesenchymal Stem CellsHematopoietic Stem Cell TransplantationHematologic DiseasesPregnancyFemaleAdultHumansAntigens, CD34Fetal BloodHematopoietic Stem CellsCoculture TechniquesCell Proliferation

Stichwörter der Autor:innen

hematopoietic stem and progenitor cells ex vivo expansionhematopoietic stem and progenitor cells transplantationmesenchymal stromal cellsperinatal tissuesumbilical cord blood

Substanzen

Antigens, CD34

Autor:innen und Institutionen

  • Pharmaceutical Biotechnology Unit, Instituto Distrital de Ciencia, Biotecnología e Innovación en Salud, Bogotá 111611, Colombia.
  • Advanced Therapies Unit, Instituto Distrital de Ciencia, Biotecnología e Innovación en Salud, Bogotá 111611, Colombia.
  • Therapeutic Evidence Group, Clinical Pharmacology, Universidad de La Sabana and Clínica Universidad de La Sabana, Chía 140013, Colombia.
  • Cord Blood Bank, Instituto Distrital de Ciencia, Biotecnología e Innovación en Salud, Bogotá 111611, Colombia.

ORCID-Profile: Ana Milena Lara, David G Hernández-Mejía, Rosa Helena Bustos, Ana-María Perdomo-Arciniegas

Förderung

  • Ministry of Science, Technology and Innovation (Colombia) and IDCBIS Resources.
  • Ministerio de Ciencia, Tecnología e Innovación

Zitieren

APA

Bonilla, X., Lara, A. M., Llano-León, M., López-González, D. A., Hernández-Mejía, D. G., Bustos, R. H., Camacho-Rodríguez, B., & Perdomo-Arciniegas, A. M. (2023). Mesenchymal Stromal Cells from Perinatal Tissues as an Alternative for Ex Vivo Expansion of Hematopoietic Progenitor and Stem Cells from Umbilical Cord Blood. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242115544

Vancouver

Bonilla X, Lara AM, Llano-León M, López-González DA, Hernández-Mejía DG, Bustos RH, et al. Mesenchymal Stromal Cells from Perinatal Tissues as an Alternative for Ex Vivo Expansion of Hematopoietic Progenitor and Stem Cells from Umbilical Cord Blood. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242115544

BibTeX
@article{Bonilla2023,
  author = {Bonilla, Ximena and Lara, Ana Milena and Llano-León, Manuela and López-González, David A and Hernández-Mejía, David G and Bustos, Rosa Helena and Camacho-Rodríguez, Bernardo and Perdomo-Arciniegas, Ana-María},
  title = {Mesenchymal Stromal Cells from Perinatal Tissues as an Alternative for Ex Vivo Expansion of Hematopoietic Progenitor and Stem Cells from Umbilical Cord Blood},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms242115544}
}
Kostenlos starten →